Noble Financial Lifts PT on Galena (GALE) to $6 Amid Outlook for GALE-401
Tweet Send to a Friend
Noble Financial boosts its price target on Galena Biopharma (Nasdaq: GALE) from $4 up to $6, while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
